✦ LIBER ✦

PCN22 IS CAPECITABINE A COST-EFFECTIVE ADJUVANT TREATMENT OF STAGE III COLON CANCER IN ONTARIO?

✍ Scribed by MC Orchard; J Hoch; SMH Alibhai

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN13 COST-EFFECTIVENESS OF ADJUVANT CAP

✍ P Tilleul; G Perrocheau; A Lafuma; E Roux 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCN59 REAL-WORLD COSTS OF ADJUVANT TREAT

✍ CWM van Gils; SS Tan; WK Redekop; CJA Punt 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

CN2 PHARMACOECONOMIC ANALYSIS OF CAPECIT

✍ TC Hsu; HH Chen; LT Chen; CR Changchien; MC Liu; HM Wang; L Yang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PCN39 EXPLORATORY COST EFFECTIVENESS ANA

✍ P Ducournau; N Latimer; E Sabate; S Walzer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Adjuvant capecitabine is at least as eff

✍ C. Lamberti; T. Sauerbruch; A Glasmacher 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 81 KB

PCN80 COST-EFFECTIVENESS ANALYSIS OF OXL

✍ T Fukuda; T Shiroiwa; T Takeuchi; K Shimozuma; Y Ohashi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB